Bortezomib and febrile neutropenia Patient Reports February 12, 2012

Bortezomib Side Effects Report #5140436-7
Bortezomib side effect was reported by a Health Professional from UNITED STATES on Oct 26, 2006. Male patient, weighting 166.7 lb, was diagnosed with multiple myeloma  and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: cough, discomfort, febrile neutropenia, nasal congestion, pharyngolaryngeal pain, rales. Bortezomib dosage: 1.3 MG/ M2 DAYS 1,4,8 AND 11 IV. During the same period patient was treated with DOXORUBICIN, GABAPENTIN, AZITHROMYCIN, PRAVASTATIN, ACYCLOVIR, ZOMETA, DOCUSATE. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5546752-9
Bortezomib side effect was reported by a Health Professional from UNITED STATES on Dec 07, 2007. Male patient, 61 years of age, weighting 203.9 lb, was diagnosed with mantle cell lymphoma and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin abnormal, platelet count abnormal, rhinitis, sinusitis . Bortezomib dosage: 2.7MG D1+4 IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, DOXORUBICIN, DEXAMETHASONE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5800630-6
Bortezomib side effect was reported by a Health Professional from UNITED STATES on July 02, 2008. Male patient, 59 years of age, weighting 198.0 lb, was diagnosed with mantle cell lymphoma and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: febrile neutropenia, infection , platelet count decreased, pneumonia , white blood cell count increased. Bortezomib dosage: 5.4 MG D1+4 IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXAN, DOXORUBICIN, DEXAMETHASONE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5389398-8
Bortezomib side effect was reported by a Health Professional from UNITED STATES on July 13, 2007. Male patient, 57 years of age, weighting 230.0 lb, was diagnosed with mantle cell lymphoma and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, leukopenia, malaise, pain in jaw. Bortezomib dosage: 2.9MG DAY 1+4 IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, DOXORUBICIN, DEXAMETHASONE, VINCRISTINE. Patient was hospitalized. Patient recovered.


Bortezomib Side Effects Report #5389375-7
Bortezomib side effect was reported by a Health Professional from UNITED STATES on July 13, 2007. Male patient, weighting 185.6 lb, was diagnosed with mantle cell lymphoma and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bortezomib dosage: unknown. During the same period patient was treated with RITUXAN, CYTOXAN, DOXORUBICIN. Patient was hospitalized. Patient recovered.